Randall Moreadith
Chief Scientific Officer · Serina Therapeutics, Inc.
- 2025
- May 26, 2026
- 30
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Randall Moreadith files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Karen J. Wilson - $55K in SER purchases and sales in the last 12 months
- Richard Peter Marshall - $20K in SER purchases and sales in the last 12 months
- Stephen K. Brannan - $2K in SER purchases and sales in the last 12 months
- Jay Venkatesan - $1K in SER purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Randall Moreadith?
Randall Moreadith is a corporate insider, tracked as Chief Scientific Officer of Serina Therapeutics, Inc. (SER). InsiderAlpha holds 30 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Randall Moreadith last file a Form 4?
The most recent primary Form 4 on record is dated 26 May 2026, one of 30 filings going back to 2025.
Has Randall Moreadith been buying or selling stock?
Recorded transactions: 0 open-market purchases and 32 open-market sales ($1.02M) across all tracked filings.
